55.JPG)
Global Biopharmaceutical Fermentation Market Size is valued at 10.5 Billion in 2024 and is predicted to reach 19.6 Billion by the year 2034 at an 6.6 % CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
The creation of novel medications depends heavily on fermentation. Patients can utilize these medications to treat illnesses like cancer, H1NI viruses, and numerous other pandemic disorders. Global biopharmaceutical fermentation has been propelled by the need to create novel medications during the forecast period. Some key market drivers include the rising older population, higher use of human services, and increased prevalence of chronic diseases globally. Due to their natural structure, cheap cost, and superior output, goods developed from fermentation are increasingly being used in various global sectors, driving the market for biopharmaceutical fermentation.
In addition, the market is anticipated to be driven by an increase in research and development activities in various domains of fermentation technology, technological developments, increased product awareness, and the introduction of new products. The increasing demand for biotechnology-based advanced products, such as monoclonal antibodies and antibody derivatives, vaccines, and monoclonal antibodies, as well as rising research and development to produce biomedical substances, is one of the key factors driving the development of the biopharmaceutical fermentation market.
The biopharmaceutical fermentation market is segmented by product, application and end users. Based on the product, the market is segmented into upstream and downstream processes. By application, the market is segmented into antibiotics, recombinant proteins, monoclonal antibodies, probiotics, and others. Based on end-user, the market is segmented into biopharmaceutical industries, contract research organizations, food industries, academic research institutes, and others.
The recombinant proteins are expected to hold a major share of the global biopharmaceutical fermentation market in 2021. Microbial systems are heavily relied upon to produce recombinant proteins, increasing the segment's dominance. Therapeutics has contributed substantially to creating recombinant therapeutic antibodies and proteins due to increased funding for research activities and the introduction of new proteins.
The biopharmaceutical industry segment is projected to increase in the global biopharmaceutical fermentation market. The growing emphasis on R&D-related spending is helping to meet the enormous demand for biopharmaceuticals. Additionally, there is an increasing need to avoid the adverse side effects of various small-molecule therapies and invasive surgical procedures, driving up the market demand for biopharmaceuticals. The market is also estimated to be driven by the rising number of FDA approvals and new product launches for various indications, especially in countries such as the US, Germany, the UK, China, and India.
North America is estimated to hold the most significant share of the market over the upcoming years. Because of rising medical costs, an advanced healthcare system, and government support for advancing bioprocess technologies. The region has also seen a significant increase in joint ventures with healthcare behemoths heavily sponsoring vaccination and biopharmaceutical R&D.
The Asia Pacific is predicted to have significant potential in the global market for biopharmaceutical fermentation because of changing economic landscapes, rapid urbanization, increased healthcare spending and investment, and the rising prevalence of chronic lifestyle diseases.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 10.5 Billion |
|
Revenue Forecast In 2034 |
USD 19.6 Billion |
|
Growth Rate CAGR |
CAGR of 6.6% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Product Type, Application, End-Use |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
GE Healthcare, Thermo Fisher Scientific Inc, Danaher Corporation, Sartorius Stedim Biotech, Merck KGaA, Eppendorf AG, Hoffmann-La Roche Ltd., Nova Biomedicals, Lonza, Becton, Dickinson and Company |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biopharmaceutical Fermentation Market Snapshot
Chapter 4. Global Biopharmaceutical Fermentation Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:
5.2.1. Upstream Process
5.2.1.1. Bioreactors/Fermenters
5.2.1.2. Bioprocess Analyzers
5.2.1.3. Process Monitoring System
5.2.1.4. Culture & Media Preparation
5.2.1.5. Other Upstream Products
5.2.2. Downstream Products
5.2.2.1. Filtration and Separation
5.2.2.2. Chromatography
5.2.2.3. Consumables and Accessories
5.2.2.4. Other Downstream Products
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
6.2.1. Antibiotics
6.2.2. Recombinant Proteins
6.2.3. Monoclonal Antibodies
6.2.4. Probiotics
6.2.5. Others
Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis
7.1. by End-user & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user:
7.2.1. Biopharmaceutical Industries
7.2.2. Contract Research Organization
7.2.3. Food Industries
7.2.4. Academic Research Institutes
7.2.5. Others
Chapter 8. Biopharmaceutical Fermentation Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Biopharmaceutical Fermentation Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
8.1.2. North America Biopharmaceutical Fermentation Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.1.3. North America Biopharmaceutical Fermentation Market revenue (US$ Million) by End-user, 2021-2034
8.1.4. North America Biopharmaceutical Fermentation Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Biopharmaceutical Fermentation Market revenue (US$ Million) by Product Type, 2021-2034
8.2.2. Europe Biopharmaceutical Fermentation Market revenue (US$ Million) by Application, 2021-2034
8.2.3. Europe Biopharmaceutical Fermentation Market revenue (US$ Million) by End-user, 2021-2034
8.2.4. Europe Biopharmaceutical Fermentation Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Biopharmaceutical Fermentation Market revenue (US$ Million) by Product Type, 2021-2034
8.3.2. Asia Pacific Biopharmaceutical Fermentation Market revenue (US$ Million) by Application, 2021-2034
8.3.3. Asia-Pacific Biopharmaceutical Fermentation Market revenue (US$ Million) by End-user, 2021-2034
8.3.4. Asia Pacific Biopharmaceutical Fermentation Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Biopharmaceutical Fermentation Market revenue (US$ Million) by Product Type, 2021-2034
8.4.2. Latin America Biopharmaceutical Fermentation Market revenue (US$ Million) by Application, 2021-2034
8.4.3. Latin America Biopharmaceutical Fermentation Market revenue (US$ Million) by End-user, 2021-2034
8.4.4. Latin America Biopharmaceutical Fermentation Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Biopharmaceutical Fermentation Market revenue (US$ Million) by Product Type, 2021-2034
8.5.2. Middle East & Africa Biopharmaceutical Fermentation Market revenue (US$ Million) by Application, 2021-2034
8.5.3. Middle East & Africa Biopharmaceutical Fermentation Market revenue (US$ Million) by End-user, 2021-2034
8.5.4. Middle East & Africa Biopharmaceutical Fermentation Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. GE Healthcare
9.2.2. Thermo Fisher Scientific Inc.
9.2.3. Danaher Corporation
9.2.4. Sartorius Stedim Biotech
9.2.5. Merck KGaA
9.2.6. Eppendorf AG
9.2.7. Hoffmann-La Roche Ltd.
9.2.8. Nova Biomedicals
9.2.9. Lonza
9.2.10. Becton Dickinson and Company
9.2.11. Other Prominent Players
By Product Type
By Application
By End User
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
